Paper19995435
Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.
Zhang B and 3 others. BMC Cancer, 2009. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. Papers, record 19995435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19995435
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ameloblastoma | Major topic |
| Jaw Neoplasms | Major topic |
| Matrix Metalloproteinase 2 | Major topic |
| Membrane Glycoproteins | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Female | |
| GPI-Linked Proteins | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Middle Aged | |
| RNA, Messenger | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Young Adult |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17158762 | Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A. | Endocr Relat Cancer | 2006 | https://conductscience.org/library/papers/17158762 | PubMed |
| 2 | 17351800 | Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. | J Gastroenterol | 2007 | https://conductscience.org/library/papers/17351800 | PubMed |
| 3 | 17328864 | Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region. | Biochem Biophys Res Commun | 2007 | https://conductscience.org/library/papers/17328864 | PubMed |
| 4 | 11747814 | The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. | Cell | 2001 | https://conductscience.org/library/papers/11747814 | PubMed |
| 5 | 19473446 | Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity. | J Oral Pathol Med | 2009 | https://conductscience.org/library/papers/19473446 | PubMed |
| 6 | 17203213 | Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit. | Int J Oncol | 2007 | https://conductscience.org/library/papers/17203213 | PubMed |
| 7 | 12738734 | RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/12738734 | PubMed |
| 8 | 16762015 | Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors. | J Oral Pathol Med | 2006 | https://conductscience.org/library/papers/16762015 | PubMed |
| 9 | 19147397 | Odontogenic tumors: a study of 1309 cases in a Chinese population. | Oral Oncol | 2009 | https://conductscience.org/library/papers/19147397 | PubMed |
| 10 | 17262820 | RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. | J Orthop Res | 2007 | https://conductscience.org/library/papers/17262820 | PubMed |
| 11 | 18588710 | Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro. | BMC Cancer | 2008 | https://conductscience.org/library/papers/18588710 | PubMed |
| 12 | 17886098 | Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours. | Pathology | 2007 | https://conductscience.org/library/papers/17886098 | PubMed |
| 13 | 18265895 | MMP-2, TIMP-2 and CD44v6 expression in non-small-cell lung carcinomas. | Ann Acad Med Singap | 2008 | https://conductscience.org/library/papers/18265895 | PubMed |
| 14 | 18493720 | Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK). | J Neurooncol | 2008 | https://conductscience.org/library/papers/18493720 | PubMed |
| 15 | 15228445 | Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. | Histopathology | 2004 | https://conductscience.org/library/papers/15228445 | PubMed |
| 16 | 15328199 | The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15328199 | PubMed |
| 17 | 18091060 | Ameloblastoma. | Am J Clin Oncol | 2007 | https://conductscience.org/library/papers/18091060 | PubMed |
| 18 | 12542835 | Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. | J Oral Pathol Med | 2003 | https://conductscience.org/library/papers/12542835 | PubMed |
| 19 | 16896992 | Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. | Int J Colorectal Dis | 2007 | https://conductscience.org/library/papers/16896992 | PubMed |
| 20 | 17236757 | Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. | Eur J Cancer | 2007 | https://conductscience.org/library/papers/17236757 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39404913 | Title of the article: diagnostic markers for odontogenic tumors: an insight: a review. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39404913 | PubMed |
| 39177897 | Factors Associated with Recurrence of Ameloblastoma: A Scoping Review. | Head Neck Pathol | 2024 | https://conductscience.org/library/papers/39177897 | PubMed |
| 34916549 | Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation. | Sci Rep | 2021 | https://conductscience.org/library/papers/34916549 | PubMed |
| 32998415 | An Integrative miRNA-mRNA Expression Analysis Reveals Striking Transcriptomic Similarities between Severe Equine Asthma and Specific Asthma Endotypes in Humans. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/32998415 | PubMed |
| 29937652 | Literature review of 86 cases of mandibular ameloblastic carcinoma. | Natl J Maxillofac Surg | 2018 | https://conductscience.org/library/papers/29937652 | PubMed |
| 29393911 | The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29393911 | PubMed |
| 28357197 | Bioinformatics Analysis Reveals Genes Involved in the Pathogenesis of Ameloblastoma and Keratocystic Odontogenic Tumor. | Int J Mol Cell Med | 2016 | https://conductscience.org/library/papers/28357197 | PubMed |
| 27272560 | Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases. | Med Sci Monit | 2016 | https://conductscience.org/library/papers/27272560 | PubMed |
| 25478440 | Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours. | J Clin Diagn Res | 2014 | https://conductscience.org/library/papers/25478440 | PubMed |
| 24931164 | RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. | Oncogene | 2015 | https://conductscience.org/library/papers/24931164 | PubMed |
| 23482687 | Molecular markers of tumor invasiveness in ameloblastoma: An update. | Ann Maxillofac Surg | 2011 | https://conductscience.org/library/papers/23482687 | PubMed |
| 22701759 | Size matters: sequential mutations in tumorigenesis may reflect the stochastic effect of mutagen target sizes. | Genes Cancer | 2011 | https://conductscience.org/library/papers/22701759 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| RECK | 8434 | PubTator's text mining | https://conductscience.org/library/genes/8434 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19995435
GET https://conductscience.org/api/papers/v1/19995435/authors